Pasithea Therapeutics Corp.
KTTANasdaqCIK 1841330HealthcareFiscal year ends Dec 31
Reports and events: 95 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-1616:06 ET | 8-K | 8.01 Other events | 0001213900-26-100515 |
| 2026-09-0916:20 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-098405 |
| 2026-08-2117:05 ET | 8-K | 3.01 Delisting notice | 0001213900-26-092672 |
| 2026-08-1416:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-090146 |
| 2026-08-0717:15 ET | DEF 14A | Proxy statementPeriod 2026-09-09 | 0001213900-26-086799 |
| 2026-05-1516:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-057837 |
| 2026-05-0417:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-051681 |
| 2026-03-3017:33 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001213900-26-036434 |
| 2026-02-2017:00 ET | 8-K | 3.01 Delisting notice | 0001213900-26-018874 |
| 2026-01-2816:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-008828 |
| 2025-12-2917:00 ET | DEF 14A | Proxy statementPeriod 2026-01-28 | 0001213900-25-126111 |
| 2025-12-1508:00 ET | 8-K | 8.01 Other events | 0001213900-25-121466 |
| 2025-12-0209:23 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-116985 |
| 2025-11-2617:04 ET | S-1/A | Registration statement, amended | 0001213900-25-115595 |
| 2025-11-2516:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-114763 |
| 2025-11-1810:50 ET | S-1 | Registration statement | 0001213900-25-111842 |
| 2025-11-1317:01 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-110093 |
| 2025-11-0407:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-105599 |
| 2025-10-2717:25 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-25-102673 |
| 2025-09-1607:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-087903 |
| 2025-09-0316:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-084062 |
| 2025-08-1415:44 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-076557 |
| 2025-07-2416:15 ET | DEF 14A | Proxy statementPeriod 2025-09-03 | 0001213900-25-067344 |
| 2025-07-1116:15 ET | 8-K | 5.08 Item not in the standard list | 0001213900-25-063277 |
| 2025-06-2716:05 ET | 8-K | 3.01 Delisting notice | 0001213900-25-059004 |
| 2025-06-2016:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-056209 |
| 2025-05-1516:31 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-044281 |
| 2025-05-0717:18 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-040725 |
| 2025-05-0109:27 ET | S-1 | Registration statement | 0001213900-25-038088 |
| 2025-04-2517:02 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-25-035640 |
| 2025-03-2416:55 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001013762-25-001646 |
| 2025-03-0621:55 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001013762-25-000233 |
| 2024-11-2617:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-102903 |
| 2024-11-1316:30 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001213900-24-097496 |
| 2024-09-3016:49 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-083408 |
| 2024-09-2608:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-081982 |
| 2024-08-1316:30 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001213900-24-068297 |
| 2024-06-2617:00 ET | 8-K | 5.07 Shareholder vote results | 0001213900-24-056205 |
| 2024-05-2809:00 ET | DEF 14A | Proxy statementPeriod 2024-06-26 | 0001213900-24-046814 |
| 2024-05-1417:15 ET | 8-K | 5.08 Item not in the standard list | 0001213900-24-043036 |
| 2024-05-1416:31 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001213900-24-042981 |
| 2024-03-2920:11 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001213900-24-027508 |
| 2024-01-1816:30 ET | 8-K | 8.01 Other events | 0001213900-24-004520 |
| 2024-01-0216:47 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-24-000296 |
| 2023-12-2811:30 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-23-099115 |
| 2023-12-1917:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-23-097013 |
| 2023-11-1316:45 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001213900-23-086198 |
| 2023-10-2617:00 ET | DEF 14A | Proxy statementPeriod 2023-11-29 | 0001013762-23-006985 |
| 2023-10-1317:00 ET | 8-K | 5.08 Item not in the standard list | 0001013762-23-003856 |
| 2023-09-1409:11 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-076515 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.